The Research Institute of Molecular Pathology (IMP) opens its new building: IMP sponsor Boehringer Ingelheim has constructed a new flagship for the Vienna Biocenter, the Life Science cluster in Vienna, with an investment of 52 million euros. Representatives from politics, industry and science celebrated the opening. more »
No single neuron produces a thought or a behavior; anything the brain accomplishes is a vast collaborative effort between cells. When at work, neurons talk rapidly to one another, forming networks as they communicate. Scientists at the Research Institute of Molecular Pathology (IMP) in Vienna and the Rockefeller University in New York are developing technology that would make it possible to record brain activity as it plays out across these networks. more »
The internationally recognized biologist Elly Tanaka has taken up a position as Senior Scientist at the Research Institute of Molecular Pathology (IMP) in Vienna. Together with her team, she will study the regeneration of injured body parts. more »
The Vienna Biocenter in the third district of Vienna has established itself as the premier location for life sciences in Central Europe and is a world-leading international bio-medical research center.